Thrombotic microangiopathy articles organized by Serendeputy, newsfeed engine for the open web

Severe Thrombocytopenia in a Patient With Otherwise Asymptomatic COVID-19
consultqd.clevelandclinic.org | 15 hours ago | Article Details | Related Articles | Share
Thromboembolic and Thrombocytopenic Events After 3 COVID-19 Vaccines in 3 Nordic Countries
jamanetwork.com | 2 days ago | Article Details | Related Articles | Share
Thrombosis in Icu, Differences between Covid-19 Vaccinated and Unvaccinated Patients
papers.ssrn.com | 1 day ago | Article Details | Related Articles | Share
- COVID-19
- I.C.U.
- Patient
- Thrombosis
- Vaccination
- 98 Tags
- 1 Tweet
- 1 Linking Site
Incidence of thrombotic microangiopathies in Quebec: insight from a laboratory centralizing ADAMTS-13 testing - Orphanet Journal of Rare Diseases
ojrd.biomedcentral.com | 4 days ago | Article Details | Related Articles | Share
2021 FAQs - FACTS about Atypical HUS - aHUS Alliance Action
ahusallianceaction.org | 4 days ago | Article Details | Related Articles | Share
BREAKING! Narsoplimab May Prevent And Treat COVID-19 Severity By Halting Complement Cascade Says Researchers - Thailand Medical News
thailandmedical.news | 5 days ago | Article Details | Related Articles | Share
Kidney News August 2022 V14#8
onlinedigeditions.com | 5 days ago | Article Details | Related Articles | Share
Gemzar, Infugem (gemcitabine) dosing, indications, interactions, adverse effects, and more
reference.medscape.com | 4 days ago | Article Details | Related Articles | Share
A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications
portlandpress.com | 4 days ago | Article Details | Related Articles | Share
- Fibrin
- Origins
- Serum amyloid A
- Therapy
- Thioflavin
- 395 Tags
- 1 Linking Site
An innovative and collaborative partnership between patients with rare disease and industry-supported registries: the Global aHUS Registry - Orphanet Journal of Rare Diseases
ojrd.biomedcentral.com | 4 days ago | Article Details | Related Articles | Share
Systemic Involvement at Entry into the Global Atypical Hemolytic Uremic Syndrome (aHUS) Registry
ashpublications.org | 4 days ago | Article Details | Related Articles | Share
Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab
sciencedirect.com | 5 days ago | Article Details | Related Articles | Share

Independent Newsfeed Enginefor the Open Web

Thrombotic microangiopathy

Severe Thrombocytopenia in a Patient With Otherwise Asymptomatic COVID-19

Thromboembolic and Thrombocytopenic Events After 3 COVID-19 Vaccines in 3 Nordic Countries

Thrombosis in Icu, Differences between Covid-19 Vaccinated and Unvaccinated Patients

Incidence of thrombotic microangiopathies in Quebec: insight from a laboratory centralizing ADAMTS-13 testing - Orphanet Journal of Rare Diseases

2021 FAQs - FACTS about Atypical HUS - aHUS Alliance Action

BREAKING! Narsoplimab May Prevent And Treat COVID-19 Severity By Halting Complement Cascade Says Researchers - Thailand Medical News

Kidney News August 2022 V14#8

Gemzar, Infugem (gemcitabine) dosing, indications, interactions, adverse effects, and more

A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications

An innovative and collaborative partnership between patients with rare disease and industry-supported registries: the Global aHUS Registry - Orphanet Journal of Rare Diseases

Systemic Involvement at Entry into the Global Atypical Hemolytic Uremic Syndrome (aHUS) Registry

Endothelial injury and thrombotic microangiopathy in COVID-19: Treatment with the lectin-pathway inhibitor narsoplimab

Independent Newsfeed Engine
for the Open Web